about
Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleedingAntiplatelet and anticoagulant therapy in elective percutaneous coronary interventionAntithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonistGuidelines on the management of secondary prophylaxis of vascular events in stable patients in primary careAntithrombotic therapy in cardiac stent patientsPlatelet and leukocyte deactivation after intracoronary stent placement in patients receiving combined antiplatelet therapyCommon variations in platelet glycoproteins: pharmacogenomic implicationsReview of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agentsEmerging drugs in peripheral arterial diseaseP2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteriesSpontaneous abdominal hematoma in a patient treated with clopidogrel and aspirinThe safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart diseaseClopidogrel in the treatment of ischaemic heart diseaseClinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI)Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentationDrug points: Ticlopidine associated with acute arthritisRecovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteersMolecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugsSelecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans.Reduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-alpha stimulated human umbilical vein endothelial cells.Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatmentPrasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile.Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agents.Clopidogrel: a review of its use in the prevention of atherothrombosis.Antiplatelet medications and their indications in preventing and treating coronary thrombosis.Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.Gender dependence for a subset of the low-abundance signaling proteome in human platelets.ADP receptor antagonists as antiplatelet therapeutics.Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines.Aspirin and clopidogrel alter core temperature and skin blood flow during heat stress.Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel.Monitoring of platelet function in the setting of glycoprotein IIb/IIIa inhibitor therapy.Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Bench to bedside: pathophysiology of acute coronary syndromes and implications for therapy.Clopidogrel in non-ST segment elevation acute coronary syndromes: an overview of the submission by the British Cardiac Society and the Royal College of Physicians of London to the National Institute for Clinical Excellence, and beyond.Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions.Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.Newer agents in antiplatelet therapy: a review.
P2860
Q24294523-736C38A5-9237-44F7-B094-4F7851BC7CDCQ24793199-8DF2FD83-C350-4435-906D-DDCFD2EF2002Q28167658-89914228-7AB6-4B8E-95B6-04C7EF96007DQ28168060-462ABFF9-2FFF-43E4-871F-3CC60E54C54FQ28174946-76A24C48-CD56-413A-BFEF-37EC002716F6Q28181524-48787650-4169-40C6-810A-ED28DD9510DAQ28191774-1BB0141E-CB9B-4523-828E-4DA3B38967F6Q28192470-CD7B705F-7782-4616-A58A-7E879C606485Q28195408-CE2C3A79-6D63-44A7-A018-186D5381BEDAQ28196936-E8719BCB-0F60-4134-BDE7-1B555DD4E3F9Q28199090-639D5516-BF27-473E-8F8A-6B03F2191ADCQ28200757-BCDCF059-A886-48FD-A0BC-88322EDF4464Q28218576-CFAF4B7E-138C-4B2F-BAC4-E28FE6E613B1Q28219418-9C0EA891-EDFA-4E1D-8044-D8360BE73920Q28254307-5C7D5149-6D50-43E3-A060-1A581DFC632CQ28344509-BED86F34-97A4-46CA-A0BD-8F62519F0442Q28354193-D664BB13-A453-42D6-A7A4-FEBD8A5D3D24Q28367095-A514E77F-FA8C-4711-BAE0-DF06EBC4DE04Q30438893-62CB4502-DAB4-4842-88CE-8C7666ABA243Q33318638-A3C5AB97-30DE-4288-A6B8-835AF0A0B942Q33581032-BCC21A0F-13B2-4119-89C4-E008D0E121C1Q33827278-44880439-575A-43B4-A517-315E1C6E399EQ34008727-35A708ED-3B89-4105-BF58-37753C4D5799Q34027525-A3B3D618-A142-469D-A6AC-5891443B223BQ34030132-40C720CF-5970-4059-A95C-2C0014EF88DBQ34111901-B1DE2AEF-C1D7-4128-A997-4AA44F5329F6Q34147112-30B40C2A-EADF-432C-9862-6F4925415E08Q34219541-75DD34C8-09DD-4268-A3B6-BBE82DC7E235Q34275908-6AF022DD-39E0-4FC4-BB3B-5AA57C472A0DQ34445660-6ACE81DC-B18E-4084-9B60-3E63AE847E1BQ34470624-4AC69266-1005-4FF0-9F51-3A9C662460B0Q34568130-F0C9ED74-B199-4E98-A862-96C0B75BDDC2Q34675287-E66E18A7-AE28-41B4-AA99-76D54174725DQ34771381-7F751EF7-7FB4-4AA9-909D-82FACFEBE743Q34930685-37DCF65A-B371-4A0B-AC3E-5FDC26098E6DQ35584682-C80BAEF8-3998-4658-8CA9-4109A016D818Q35656802-9F21486B-B7C8-4B69-A50B-9578AC3AF428Q35752584-6047515E-A393-49D5-BA7C-E9185EC2037AQ36040667-C8B7EFD6-6CD1-4149-A3DB-8856FF528AA5Q36085620-F75AB072-9A6D-4946-821D-C848420A778C
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Ticlopidine and clopidogrel.
@ast
Ticlopidine and clopidogrel.
@en
type
label
Ticlopidine and clopidogrel.
@ast
Ticlopidine and clopidogrel.
@en
prefLabel
Ticlopidine and clopidogrel.
@ast
Ticlopidine and clopidogrel.
@en
P1433
P1476
Ticlopidine and clopidogrel.
@en
P2093
Fitzgerald DJ
P304
P356
10.1161/01.CIR.100.15.1667
P407
P577
1999-10-01T00:00:00Z